Profile data is unavailable for this security.
About the company
Nuwellis, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
- Revenue in USD (TTM)8.90m
- Net income in USD-19.93m
- Incorporated2002
- Employees59.00
- LocationNuwellis Inc12988 Valley View RdEDEN PRAIRIE 55344-3657United StatesUSA
- Phone+1 (952) 345-4200
- Fax+1 (302) 636-5454
- Websitehttps://www.nuwellis.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Guided Therapeutics Inc | 82.00k | -3.23m | 3.66m | 4.00 | -- | -- | -- | 44.68 | -0.0623 | -0.0623 | 0.0016 | -0.0721 | 0.0374 | 0.0904 | 11.71 | 20,500.00 | -137.80 | -136.13 | -- | -- | 32.93 | 29.39 | -3,685.37 | -3,666.67 | 0.1138 | -11.13 | -- | -- | 653.85 | 11.45 | 24.40 | -- | -- | -- |
| Helius Medical Technologies Inc | -100.00bn | -100.00bn | 3.69m | 26.00 | -- | 0.6527 | -- | -- | -- | -- | -- | 2.24 | -- | -- | -- | -- | -- | -98.37 | -- | -143.57 | -- | 37.27 | -- | -1,580.66 | 3.26 | -- | -- | -- | -18.17 | 6.14 | 37.11 | -- | -- | -- |
| Catheter Precision Inc | 439.00k | -6.85m | 3.81m | 14.00 | -- | 0.2057 | -- | 8.68 | -1.03 | -1.03 | 0.0659 | 2.45 | 0.0115 | 0.3759 | 5.74 | 31,357.14 | -17.89 | -- | -19.64 | -- | 94.31 | -- | -1,559.68 | -- | 0.8047 | -- | 0.004 | -- | 3,057.14 | -- | -165.67 | -- | -- | -- |
| Heart Test Laboratories Inc | 18.60k | -6.39m | 4.46m | 12.00 | -- | 50.18 | -- | 240.04 | -0.4912 | -0.4912 | 0.0009 | 0.1357 | 0.0026 | 0.009 | 2.53 | 1,550.00 | -89.51 | -- | -120.71 | -- | 67.31 | -- | -34,362.42 | -- | 4.70 | -16.41 | 0.0547 | -- | -64.16 | -- | -31.61 | -- | -- | -- |
| SINTX Technologies Inc | 2.78m | -8.88m | 4.74m | 43.00 | -- | 0.0201 | -- | 1.71 | -389.94 | -389.94 | 74.21 | 383.24 | 0.138 | 1.62 | 5.84 | 64,534.88 | -44.03 | -45.71 | -57.11 | -57.36 | 67.96 | 58.47 | -318.99 | -681.80 | 1.67 | -- | 0.0229 | -- | 68.29 | 94.24 | 49.75 | -- | 54.10 | -- |
| Nuwellis Inc | 8.90m | -19.93m | 4.98m | 59.00 | -- | 2.12 | -- | 0.5603 | -8.30 | -8.30 | 2.73 | 0.1304 | 0.7076 | 1.55 | 7.04 | 150,762.70 | -143.62 | -98.07 | -216.07 | -122.48 | 57.41 | 55.22 | -202.97 | -230.51 | 0.7092 | -4.75 | 0.00 | -- | 3.76 | 12.14 | -55.78 | -- | 4.61 | -- |
| Arch Therapeutics Inc | 130.55k | -8.43m | 5.05m | 8.00 | -- | -- | -- | 38.71 | -3.68 | -3.68 | 0.0425 | -2.45 | 0.0833 | 0.0637 | -- | 16,318.75 | -538.25 | -188.28 | -- | -804.63 | 33.37 | -- | -6,458.14 | -26,945.92 | 0.0164 | -1.27 | -- | -- | 383.83 | -- | -32.35 | -- | -21.76 | -- |
| Vapotherm Inc | 70.07m | -54.94m | 5.16m | 182.00 | -- | -- | -- | 0.0737 | -8.62 | -8.62 | 11.00 | -11.02 | 0.8122 | 1.46 | 7.53 | 385,011.00 | -63.68 | -49.73 | -587.27 | -62.54 | 45.28 | 43.56 | -78.40 | -78.99 | 0.1259 | -1.27 | 2.59 | -- | 2.80 | 10.14 | 48.62 | -- | -10.38 | -- |
| Hawkeye Systems Inc | 0.00 | -804.18k | 5.20m | 44.00 | -- | -- | -- | -- | -0.1186 | -0.1186 | 0.00 | -0.29 | 0.00 | -- | -- | -- | -66.07 | -330.11 | -- | -- | -- | -- | -- | -218.49 | -- | -2.78 | 10.45 | -- | -- | -- | 4.85 | -- | -- | -- |
| ADM Tronics Unlimited Inc | 2.85m | -716.86k | 5.34m | 7.00 | -- | 4.84 | -- | 1.88 | -0.0106 | -0.0106 | 0.0421 | 0.0163 | 0.9772 | 3.85 | 4.25 | -- | -24.62 | -11.45 | -38.81 | -15.77 | 38.45 | 43.73 | -25.19 | -15.28 | 1.24 | -- | 0.2902 | -- | 14.66 | -0.4159 | 93.04 | -- | -- | -- |
| Nexalin Technology Inc | 158.86k | -4.94m | 5.39m | 6.00 | -- | 2.32 | -- | 33.91 | -0.6676 | -0.6676 | 0.0215 | 0.3129 | 0.0363 | 0.1778 | 44.01 | 26,476.67 | -112.76 | -- | -139.94 | -- | 82.54 | -- | -3,110.58 | -- | 4.75 | -- | 0.00 | -- | -91.62 | -- | -173.80 | -- | -- | -- |
| Pressure Biosciences Inc | 2.27m | -29.56m | 5.43m | 15.00 | -- | -- | -- | 2.39 | -1.70 | -1.70 | 0.1299 | -1.22 | 1.02 | 2.28 | 9.17 | 151,505.30 | -1,074.63 | -643.54 | -- | -- | 6.89 | 34.75 | -1,050.30 | -798.21 | 0.0185 | -0.4182 | -- | -- | -13.64 | -5.05 | 21.52 | -- | -34.47 | -- |
| ReShape Lifesciences Inc | 8.34m | -10.92m | 5.87m | 31.00 | -- | 1.29 | -- | 0.7039 | -2.30 | -2.30 | 0.7319 | 0.1933 | 0.6781 | 0.8178 | 4.52 | 268,871.00 | -88.83 | -136.06 | -162.20 | -194.32 | 65.85 | 56.30 | -130.99 | -408.36 | 1.26 | -- | 0.00 | -- | -22.79 | -0.9474 | 75.36 | -- | -49.29 | -- |
| Encision Inc | 6.87m | -448.00k | 5.88m | 31.00 | -- | 2.68 | -- | 0.8568 | -0.0381 | -0.0381 | 0.5835 | 0.1863 | 1.64 | 1.96 | 7.84 | 221,520.00 | -10.69 | -1.07 | -14.05 | -1.46 | 50.54 | 52.27 | -6.52 | -0.613 | 1.08 | -6.22 | 0.1123 | -- | -4.17 | -3.44 | -393.90 | -- | 12.89 | -- |
| Fuse Medical Inc | 18.40m | 3.63m | 6.06m | 31.00 | 2.28 | -- | 1.64 | 0.3295 | 0.036 | 0.036 | 0.2307 | -0.0031 | 0.9593 | 0.7018 | 5.75 | 593,671.90 | 18.91 | 0.7504 | 48.45 | 1.35 | 64.95 | 54.98 | 19.72 | 0.6552 | 0.3143 | -1.13 | 1.12 | -- | -8.67 | -6.72 | 295.11 | 34.66 | -- | -- |
| Vivos Therapeutics Inc | 13.36m | -15.64m | 6.29m | 114.00 | -- | 9.15 | -- | 0.4709 | -11.00 | -11.00 | 8.73 | 0.2131 | 0.9247 | -- | 31.59 | 117,219.30 | -108.24 | -89.72 | -243.30 | -149.70 | 58.90 | 70.20 | -117.06 | -113.15 | -- | -- | 0.00 | -- | -13.87 | 29.48 | 43.04 | -- | -8.48 | -- |
Data as of May 30 2024. Currency figures normalised to Nuwellis Inc's reporting currency: US Dollar USD
20.00%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| S.H.N. Financial Investments Ltd.as of 26 Apr 2024 | 1.04m | 15.32% |
| Citadel Securities LLCas of 31 Mar 2024 | 115.48k | 1.70% |
| Virtu Americas LLCas of 31 Mar 2024 | 77.56k | 1.14% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 49.96k | 0.73% |
| Two Sigma Securities LLCas of 31 Mar 2024 | 26.04k | 0.38% |
| G1 Execution Services LLCas of 31 Mar 2024 | 13.03k | 0.19% |
| HRT Financial LLCas of 31 Mar 2024 | 11.87k | 0.18% |
| Goldman Sachs & Co. LLC (Private Banking)as of 31 Mar 2024 | 11.85k | 0.17% |
| Geode Capital Management LLCas of 31 Mar 2024 | 11.22k | 0.17% |
| Tower Research Capital LLCas of 31 Mar 2024 | 1.68k | 0.03% |
More ▼
Data from 31 Mar 2024 - 01 May 2024Source: FactSet Research Systems Inc.
